WPRIM Management System> DCMS> Kidney Research and Clinical Practice> 2019> 38> 2

Volume: 38 Issue: 2

1. Hemolytic uremic syndrome caused by Escherichia fergusonii infection Page:253—255
2. Monitoring globotriaosylsphingosine in a Korean male patient with Fabry disease Page:250—252
3. Impact of body mass index on survival in patients undergoing peritoneal dialysis: Analysis of data from the Insan Memorial End-Stage Renal Disease Registry of Korea (1985–2014) Page:239—249
4. Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism Page:229—238
5. Fracture risk in chronic kidney disease: A Korean population-based cohort study Page:220—228
6. Comparisons between different blood pressure measurement techniques in patients with chronic kidney disease Page:212—219
7. Serum alkaline phosphatase and γ-glutamyl transferase in acute pyelonephritis Page:205—211
8. Sub-morbid dehydration-associated glomerular hyperfiltration: An emerging reality? Page:196—204
9. Renal tubular P-glycoprotein expression is reduced in plasma cell disorders Page:186—195
10. Adipose tissue-derived mesenchymal stromal cells for treating chronic kidney disease: A pilot study assessing safety and clinical feasibility Page:176—185
11. Analysis of mortality risk from Korean hemodialysis registry data 2017 Page:169—175
12. Online hemodiafiltration and mortality risk in end-stage renal disease patients: A critical appraisal of current evidence Page:159—168
13. New insights into the transcriptional regulation of aquaporin-2 and the treatment of X-linked hereditary nephrogenic diabetes insipidus Page:145—158
14. Limited usefulness of calcimimetics for secondary hyperparathyroidism in non-dialysis chronic kidney disease Page:141—144
15. Blood pressure measurement in patients with chronic kidney disease: from clinical trial to clinical practice Page:138—140
16. Is high fluid intake good for the kidney? Page:135—137
17. Use of mesenchymal stem cells for chronic kidney disease Page:131—134